menu
    • menu
    [{"orgOrder":0,"company":"JIAOZUO JOINCARE BIOTECHNOLOGICAL CO LTD","sponsor":"TaiGen Biotechnology","pharmaFlowCategory":"D","therapeuticArea":"Infections and Infectious Diseases","country":"TAIWAN","productType":"Small molecule","year":"2023","type":"Licensing Agreement","leadProduct":"TG-1000","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"JIAOZUO JOINCARE BIOTECHNOLOGICAL CO LTD","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"JIAOZUO JOINCARE BIOTECHNOLOGICAL CO LTD \/ JIAOZUO JOINCARE BIOTECHNOLOGICAL CO LTD","highestDevelopmentStatusID":"10","companyTruncated":"JIAOZUO JOINCARE BIOTECHNOLOGICAL CO LTD \/ JIAOZUO JOINCARE BIOTECHNOLOGICAL CO LTD"}]

    Find Clinical Drug Pipeline Developments & Deals by JIAOZUO JOINCARE BIOTECHNOLOGICAL CO LTD

    Menu

    JIAOZUO JOINCARE BIOTECHNOLOGICAL CO LTD

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
    filter

    Year

    filter

    DEALS // DEV.

    filter

    Country

    filter
    Sponsor
    filter

    Therapeutic Area

    filter

    Study Phase

    filter

    Deal Type

    filter

    Product Type

    filter

    Dosage Form

    filter

    Lead Product

    filter

    Target

    refresh Filters
    refresh Reset Filter
    refresh Reset Filter
    price-trend All Developments

    Therapeutic Area by Lead Product

    ForexGraph

    Study Phase by Lead Product

    ForexGraph

    Company by Lead Product

    ForexGraph

    Top Deals by Deal Size (USD bn)

    ForexGraph

    01

    JIAOZUO JOINCARE BIOTECHNOLOGICAL CO LTD

    China arrow
    BePharma
    Not Confirmed

    JIAOZUO JOINCARE BIOTECHNOLOGICAL CO LTD

    China arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : TG-1000

    Therapeutic Area : Infections and Infectious Diseases

    Study Phase : Phase II

    Recipient : TaiGen Biotechnology

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    TaiGen Enters Exclusive License Agreement with Joincare for TG-1000 in China

    Details : Joincare will develop and commercialize TG-1000, a novel pan-influenza antiviral by interrupting viral replication and transmission via a cap-snatching mechanism, revealing efficacy against influenza-A, influenza-B, avian flu H7N9, and Tamiflu-resistant ...

    Product Name : TG-1000

    Product Type : Small molecule

    Upfront Cash : $2.9 million

    March 22, 2023

    Lead Product(s) : TG-1000

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Phase II

    Recipient : TaiGen Biotechnology

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth